What Applied Mat AMAT does that builds long term value Q1 2026 Profit Exceeds Views Why Ramaco METCZ is still under the radar Slow Grind 20260508 AVAL Grupo Aval revenue surges 13 YoY to 174T in Q2 yet shares decline 154 on profit concerns Voyager Therapeutics VYGR Stock Support Breakdown Risk Q4 2025 EPS Beats Forecasts The valuation case for Processa Pharmaceuticals PCSA that is hard to ignore 436 20260508 OPY Oppenheimer shares slide 771 following the release of its Q1 2025 quarterly earnings report What MGP Ingredients MGPI is investing to grow Q1 2026 EPS Beats Forecasts New York Times Pips Puzzle A New Digital Engagement Driver for the Media Giant Shoals SHLS Reports Strong Q1 2026 Revenue NA EPS Beats